Company profile
New safer medicines to treat inflammatory diseases | Carocell Bio
Carocell Bio are researching and developing revolutionary new treatments for burns, atopic dermatitis and scar prevention, burns and more
Financial period: 1 Dec 2023 to 30 Nov 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0NDA5NjY3MGFkaXF6a2N4
Published 19 Nov 2024 11:04
CS01 | Transaction MzQ0Mjc4MjEzNmFkaXF6a2N4
Published 12 Nov 2024 09:46
AP02 | Transaction MzQ0MDY0Mzg3M2FkaXF6a2N4
Published 23 Oct 2024 08:28
AA | Transaction MzQzMzg0MTk2MmFkaXF6a2N4
Published 29 Aug 2024 16:41
Company registered at Companies House
1 Dec 2021 to 31 Jan 2022
NHS Burns Services treated more than 15,000 patients for burns and scalds in 2017 with costs exceeding £20million and the most severe burns costing £95,000 to treat. The true cost (hospital treatment/operative costs/dressings/staffing/lost productivity/physical and mental health implications) can reach ~£126,000/patient, totaling £1.9billion/year for the ...
1 Jul 2020 to 31 Jan 2022
NHS Burns Services treated more than 15,000 patients for burns and scalds in 2017 with costs exceeding £20million and the most severe burns costing £95,000 to treat. The true cost (hospital treatment/operative costs/dressings/staffing/lost productivity/physical and mental health implications) can reach ~£126,000/patient, totaling £1.9billion/year for the ...
